Literature DB >> 7397446

Differential sensitivity of hypothalamic dopaminergic and noradrenergic neurones to pharmacological manipulation.

F Karoum, S G Speciale, R J Wyatt.   

Abstract

The effects of apomorphine (Apo), haloperidol (Hal), reserpine, phenyoxybenzamine, oxotremorine and scopolamine on hypothalamic caatecholamines and metabolites were assessed. All these drugs, except Apo, significantly changed the hypothalamic concentration of 3-methoxy-4-hydroxyphenylglycol (MHPG), thus suggesting parallel changes in noradrenaline (NA) metabolism and turnover. Hal increased MHPG, an effect which was reversed by Apo pretreatment. Oxotremorine and scopolamine respectively increased and decreased MHPG, reserpine decreased NA and increased MHPG. Phenoxybenzamine increased MHPG without altering NA concentrations. Dopamine and its metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) were not changed by Apo and Hal, but were influenced by the other drugs. These results indicate that NA in the hypothalamus is influenced by both cholinergic and dopaminergic events occurring in the brain and that dopaminergic neurones in this organ are different in their biochemical and pharmacological characteristics from neurones present in other central and peripheral systems.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7397446      PMCID: PMC2044283          DOI: 10.1111/j.1476-5381.1980.tb07020.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

1.  The dynamics of dopamine metabolism in various regions of rat brain.

Authors:  F Karoum; N H Neff; R J Wyatt
Journal:  Eur J Pharmacol       Date:  1977-08-15       Impact factor: 4.432

2.  Central noradrenergic activity and the formation of glycol sulfate metabolites of brain norepinephrine.

Authors:  E A Stone
Journal:  Life Sci       Date:  1976-11-15       Impact factor: 5.037

3.  Trans-synaptic modulation of dopamine metabolism in the rat superior cervical ganglion.

Authors:  F Karoum; C K Garrison; N Neff; R J Wyatt
Journal:  J Pharmacol Exp Ther       Date:  1977-06       Impact factor: 4.030

Review 4.  Catecholamines and prolactin secretion.

Authors:  J Meites
Journal:  Adv Biochem Psychopharmacol       Date:  1977

5.  Sulphate ester formation from catecholamine metabolites and pyrogallol in rat brain in vivo.

Authors:  D Eccleston; I M Ritchie
Journal:  J Neurochem       Date:  1973-09       Impact factor: 5.372

6.  Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite.

Authors:  S M Schanberg; J J Schildkraut; G R Breese; I J Kopin
Journal:  Biochem Pharmacol       Date:  1968-02       Impact factor: 5.858

7.  Prolactin and growth hormone production as influenced by catecholamines and agents that affect brain catecholamines.

Authors:  R M MacLeod; E H Fontham; J E Lehmeyer
Journal:  Neuroendocrinology       Date:  1970       Impact factor: 4.914

8.  Effect of psychotropic drugs on 3,4-dihydroxyphenylacetic acid (DOPAC) content in the medial basal hypothalamus.

Authors:  A Argiolas; E Paglietti; F Fadda; B P Quarantotti; G L Gessa
Journal:  Life Sci       Date:  1978-02       Impact factor: 5.037

9.  Effect of prolactin on dopamine synthesis in medial basal hypothalamus: evidence for a short loop feedback.

Authors:  N A Perkins; T C Westfall; C V Paul; R MacLeod; A D Rogol
Journal:  Brain Res       Date:  1979-01-19       Impact factor: 3.252

10.  Presence of free, sulfate and glucuronide conjugated 3-methoxy-4-hydroxyphenylglycol (MHPG) in human brain, cerebrospinal fluid and plasma.

Authors:  F Karoum; J Moyer-Schwing; S G Potkin; R J Wyatt
Journal:  Brain Res       Date:  1977-04-15       Impact factor: 3.252

View more
  2 in total

1.  Differential response to cholinergic stimulation in psychogenitically selected rat lines.

Authors:  J R Martin; P Driscoll; C Gentsch
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

2.  Free and conjugated 3,4-dihydroxyphenylacetic acid and homovanillic acid in brain dopaminergic areas at basal state and after pipotiazine activation.

Authors:  E Tavitian; L Peyrin; Y Dalmaz; R Favre; M De Haut; J M Cottet-Emard
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.